Basic Summary for Hallervorden-Spatz disease

Main name of condition: Hallervorden-Spatz disease

What is Hallervorden-Spatz disease?
  Brief description of Hallervorden-Spatz disease: Nerve disorder causing movement problems.
  Parent types of Hallervorden-Spatz disease: Genetic Disease
  Organs Affected by Hallervorden-Spatz disease: nerves, muscles

How many people get Hallervorden-Spatz disease?
Prevalance of Hallervorden-Spatz disease: rare

How serious is Hallervorden-Spatz disease?
Prognosis of Hallervorden-Spatz disease: Poor. Death common within 10 years.
Prognosis of Hallervorden-Spatz disease: The prognosis for individuals with Hallervorden-Spatz disease is poor. The course of the disorder is relentlessly progressive. Death usually occurs approximately 10 years after onset. In a few cases, survival may extend for several decades. ¹

What causes Hallervorden-Spatz disease?
Class of Condition for Hallervorden-Spatz disease: genetic

What are the symptoms of Hallervorden-Spatz disease?
Symptoms of Hallervorden-Spatz disease: see symptoms of Hallervorden-Spatz disease

Can anyone else get Hallervorden-Spatz disease?
Contagion of genetic conditions: generally not; see details in contagion of genetic diseases.
Inheritance of genetic conditions: see details in inheritance of genetic diseases.

How is it treated?
Treatments for Hallervorden-Spatz disease: see treatments for Hallervorden-Spatz disease

Society issues for Hallervorden-Spatz disease
Hospitalization statistics for Hallervorden-Spatz disease: The following are statistics from various sources about hospitalizations and Hallervorden-Spatz disease:

0.0001% 19) of hospital consultant episodes were for Hallervorden-Spatz disease in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
72% of hospital consultant episodes for Hallervorden-Spatz disease required hospital admission in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
46% of hospital consultant episodes for Hallervorden-Spatz disease were for men in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
54% of hospital consultant episodes for Hallervorden-Spatz disease were for women in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
53% of hospital consultant episodes for Hallervorden-Spatz disease required emergency hospital admission in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
6.6 days was the mean length of stay in hospitals for Hallervorden-Spatz disease in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
3 days was the median length of stay in hospitals for Hallervorden-Spatz disease in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
18 was the mean age of patients hospitalised for Hallervorden-Spatz disease in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
17% of hospital consultant episodes for Hallervorden-Spatz disease occurred in 15-59 year olds in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
25% of hospital consultant episodes for Hallervorden-Spatz disease occurred in people over 75 in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
2% of hospital consultant episodes for Hallervorden-Spatz disease were single day episodes in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
0.0002% (93) of hospital bed days were for Hallervorden-Spatz disease in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)

Footnotes:
1. excerpt from NINDS Hallervorden-Spatz Disease Information Page: NINDS

Medical Tools & Articles:

Next articles:

Medical Articles: